HQL
ETF / Mutual Fund
Nyse American
abrdn Life Sciences Investor, Inc.
Financials
$12.61
-$0.09 (-0.72%)
Price Chart
Overview
About HQL
abrdn Life Sciences Investors operates as a non-diversified closed-end management investment company. Its investment objective is to seek long-term capital appreciation by investing primarily in securities of Life Sciences companies. It invests in securities of public and private companies that are believed by the Fund's Investment Adviser, abrdn Inc to have significant potential for above-average growth.
AUM
$376.3M
Volume
1.9M
Avg. Volume
1.7M
Expense Ratio
Top Holdings
Other
100.00%Sector Allocation
Other100.00%
Country Allocation
Other100.00%
Fund Information
Latest News for HQL
Risk & Correlation Analysis
Market Correlation
0.78
Moderate Correlation
Volatility
Low (0.18)
Relative to market
Macro Factor Sensitivities
Interest Rates
Low Sensitivity
Inflation
Low Sensitivity
GDP Growth
Medium Sensitivity
Liquidity
Low Sensitivity
Commodity Prices
Low Sensitivity
Credit Quality
Low Sensitivity
Portfolio Impact
Forecasts & Predictions
1-Month Target
$XXX.XX
+X.X% Potential
3-Month Target
$XXX.XX
+X.X% Potential
12-Month Target
$XXX.XX
+X.X% Potential
Technical Analysis
Based on technical indicators and chart patterns, HQL shows...
AI Sentiment Analysis
Market sentiment analysis indicates...
Key Statistics
AUM$376.3M
Volume1.9M
Expense Ratio
Related Securities
Pricing info last updated June 18, 2025 (after market close)Other info last updated April 2, 2025